DJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc The Vanguard Group, Inc. ( irh) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc 30-Aug-2023 / 13:18 GMT/BST=----------------------------------------------------------------------------------------------------------------------
The Vanguard Group, Inc. Form 8.3 30-Aug-2023 / 13:18 GMT/BST =---------------------------------------------------------------------------------------------------------------------- Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION a. Full name of discloser The Vanguard Group, Inc. b.
Class of relevant security USUSD0.0001 ordinary shares Interests Short positions Number % Number % 1. Relevant securities owned and/or controlled 21,584,133 9.43% 2. Cash-settled derivatives 3. Stock-settled derivatives and agreements to purchase/ sell Total 21,584,133 9.43% All interests and all short positions should be disclosed.
Class of Product Exercising/ Exercise relevant description exercised Number of price per security e.g. call against securities unit option Other dealings 4.
Is a Supplemental Form 8 attached? No Date of disclosure 30 August 2023 Contact name Shawn Acker Telephone number 001-610-669-6713 Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.
Italia Ultime Notizie, Italia Notizie
Similar News:Puoi anche leggere notizie simili a questa che abbiamo raccolto da altre fonti di notizie.
- The Vanguard Group, Inc.: Horizon Therapeutics PlcDJ Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc The Vanguard Group, Inc. ( irsh) Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics Plc 28-Aug-2023 / 15:33 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Leggi di più »
- The Vanguard Group, Inc.: Dechra Pharmaceuticals PLCDJ Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 28-Aug-2023 / 15:31 GMT/BST=----------------------------------------------------------------------------------------------------------------------
Leggi di più »
DeFi Technologies Inc.-Tochter Valour Inc. bringt 3 neue Produkte auf NGM auf den MarktZug, Schweiz, und Toronto, Kanada (ots/PRNewswire) - - Valour Inc., das Tochterunternehmen von DeFi Technologies, führt drei auf EUR lautende Produkte auf NGM ein: Valour Ethereum Zero EUR, Valour Solana
Leggi di più »
Vonovia SE (ex Deutsche Annington) Conviction Buy List (Goldman Sachs Group Inc.) 29.08.2023 | AnalyseVonovia SE (ex Deutsche Annington) Conviction Buy List (Goldman Sachs Group Inc.) 29.08.2023 | Analyse | finanzen.net
Leggi di più »
Adhoc: TX Group: TX Group steigert Betriebsergebnis deutlichTX Group / Schlagwort(e): Halbjahresergebnis TX Group steigert Betriebsergebnis deutlich 29.08.2023 / 06:29 CET/CEST Veröffentlichung einer Ad-hoc-Mitteilung gemäss Art. 53 KR Für
Leggi di più »